Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2003
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203952 Novel processes for making- and a new crystalline form of- leflunomide
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203878 Comprises non-hydrated hydrogel, superdisintegrant, and tannic acid; for treatment of metastatic bone diseases (hypercalcemia)
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203060 Electrodeposition of very fine metal particles, e.g. copper, in a plant extract juice by electrolysis using the desired metal as an electrode to form a medicinal powder; refining of alloys, e.g., removal of gold metal from an alloy (jewelry)
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203051 Plant extracts for the treatment of increased bone resorption
10/30/2003US20030202960 Therapeutic angiogenic factors and methods for their use
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003CA2484017A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481120A1 Method for treating and preventing hyperparathyroidism
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356811A1 Preventives or remedies for arthritis
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355908A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355665A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/29/2003EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355643A2 Epoxyvibsanin b
10/29/2003EP1355642A2 INHIBITION OF NF-(k)B BY TRITERPENE COMPOSITIONS
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1149092B1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/29/2003EP1107940B1 Vitamin d3 mimics
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP0971888B1 2-alkyl-19-nor-vitamin d compounds
10/29/2003EP0915911B1 Parathyroid hormone analogues for the treatment of osteoporosis
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452499A Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1452490A Composition and method for intervening neuronal death using sulfasalazine
10/29/2003CN1452488A Treatment of inflammatory disorders
10/29/2003CN1452486A Pharmaceutical composition and use method
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451432A Medicine for treating neck, shoulder, waist and leg pains
10/29/2003CN1451430A Medicine composition for treating ischemic necrosis of femur head and preparing process thereof
10/29/2003CN1451421A ÔÇ£GukangÔÇØ patch
10/29/2003CN1451404A Medicine for treating bone tuberculosis
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638920 Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
10/28/2003US6638907 Laminin 8 and methods for its use
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087375A1 Cartilage differentiation regulating gene
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087120A1 Estrone derivative and process for producing the same
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
1 ... 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 ... 820